'I think it's not a good idea,' said the House speaker about the president's choice to take the drug before it's even been officially approved to treat coronavirus
You'll get the latest updates on this topic in your browser notifications.
"I happen to be taking it. I happen to be taking it — hydroxychloroquine," Trump, 73, told reporters on Monday, adding that he started taking the unproven drug "a couple of weeks ago." "He's our president and I would rather he not be taking something that has not been approved by the scientists," Pelosi told Cooper, "especially in his age group and his, shall we say, weight group: 'morbidly obese,' they say."found he weighed 243 poundsAt the press briefing when Trump raised concerns by personally touting the drug, he said, "If it is not good, I will tell you right.
"I'm not going to get hurt by it. It has been around for 40 years for malaria, for lupus, for other things. I take it," he shared, claiming that he has
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nancy Pelosi Says 'Morbidly Obese' Trump Shouldn't Take Malaria DrugSpeaking to CNN's Anderson Cooper, the House Speaker said she would 'rather the president not to take something not approved by the scientists” as a treatment for COVID-19.
Read more »
Nancy Pelosi Says ‘Morbidly Obese’ Trump Shouldn’t Take Hydroxychloroquine for CoronavirusSpeaker of the House Nancy Pelosi said that President Trump shouldn’t be taking the antimalarial drug hydroxychloroquine because he’s “morbidly obese” and at risk for negati…
Read more »
Pelosi says Trump firing of State Department inspector general could be 'unlawful' if done in retaliationTrump can fire any federal employee, but 'if it looks like it's in retaliation ... that could be unlawful,' Pelosi said.
Read more »
Pelosi slams Trump for taking hydroxychloroquine, calls him 'morbidly obese'The FDA warns against the drug&39;s outside of a hospital setting or a clinical trial due to risk of heart rhythm problems.
Read more »